ArticleCureus2025

Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India.

Arijit Nag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.